BioCentury
ARTICLE | Tools & Techniques

Visualizing new partnerships

December 12, 2005 8:00 AM UTC

Seeing is Believing

In the last three to four years, the major instrument companies have concluded that the potential impact of molecular imaging on drug discovery and development justifies major investments in the field. As a result, companies such as GE Healthcare, Philips Medical Systems, Siemens Medical Solutions and Toshiba Corp. all have gotten into the act. ...